Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04865133 · ClinicalTrials.gov registry record
Efficacy and Safety of COVID-19 Vaccine in Cancer Patients
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 89
- Enrollment target
NCT04865133: Completed study, sponsored by Mayo Clinic.
NCT04865133 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04865133 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 89 participants
- Enrollment target
Study Summary
This study gathers information about how a cancer patient responds to COVID-19 vaccine during cancer treatment compared to healthy individuals. The information gained may help determine how effective currently available COVID-19 vaccines are in cancer patients receiving chemotherapy and learn more regarding how long an immune response will last compared to healthy individuals.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Electronic Health Record Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2021-03-31 |
| Est. Completion | 2022-09-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04865133
The ClinicalTrials.gov registry entry for NCT04865133 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biospecimen Collection is the first listed.
NCT04865133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04865133 about?
NCT04865133 is a clinical study titled "Efficacy and Safety of COVID-19 Vaccine in Cancer Patients". This study gathers information about how a cancer patient responds to COVID-19 vaccine during cancer treatment compared to healthy individuals. The information gained may help determine how effective currently available COVID-19 vaccines are in cancer patients receiving chemotherapy and learn more r...
What is the current status of trial NCT04865133?
This trial is currently completed. The enrollment target is 89 participants. The study started on 2021-03-31. Estimated completion is 2022-09-08.
What interventions are being tested in trial NCT04865133?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT04865133?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.